Biomerica has received U.S. Food and Drug Administration 510(k) clearance for its Hp Detect Stool Antigen ELISA test, a new product that is designed to detect the presence of the H. pylori bacteria, which infects approximately 35% of the U.S. population. H. pylori infection is a disease which affects half the population of the world.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on BMRA:
- Biomerica Received US FDA 510(k) Clearance for Their Hp Detect™ ELISA Test Product Designed to Detect the Presence of the H. pylori Bacteria That infects Approximately 35% of the U.S. Population
- Biomerica to Participate in 14th Annual Craig-Hallum Alpha Select Conference on November 16
- Biomerica Expands inFoods IBS Reach with Addition of Several New GI Groups
- Biomerica expands inFoods IBS reach with addition of several new GI groups